FDA Inspection
The American National Red Cross Diagnostic Manufacturing DivisionThe American National Red Cross Diagnostic Manufacturing Division – FDA Inspection, Apr 27, 2018
Record Details
This FDA Inspection record concerns The American National Red Cross Diagnostic Manufacturing Division, with an inspection on April 27, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 27, 2018
- Product Type
- Biologics
View Company Profile
ID · 5dc4660d-78fe-4ef7-b3e2-2f962571eab8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1058813
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of The American National Red Cross Diagnostic Manufacturing Division
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 10, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 13, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 15, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 29, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 4, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The American National Red Cross Diagnostic Manufacturing Division
- FDA Inspection 1326648 - 2026-07-10
- FDA Inspection 1231137 - 2024-02-13
- FDA Inspection 991584 - 2016-06-15
- FDA Inspection 898271 - 2014-08-29
- FDA Inspection 752096 - 2011-11-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.